All articles by Divya Tirumalaraju

  1. Syapse and Roche to bolster precision medicine for cancer

    US-based Syapse has formed a strategic alliance with Roche to accelerate product development and clinical delivery for offering precision medicine…
    Read More…

    11 Jan
  2. Rhythm Pharma uses WuXi’s AI for obesity disorder therapy

    US-based Rhythm Pharmaceuticals has leveraged contract genomics organisation WuXi NextCODE’s artificial intelligence (AI) deep learning capabilities to identify genetic markers…
    Read More…

    11 Jan
  3. FDA agrees to review Merck’s NDAs for HIV drug doravirine

    The US Food and Drug Administration (FDA) has accepted to review two new drug applications (NDAs) submitted by Merck for…
    Read More…

    10 Jan
  4. Regeneron forms consortium to advance human gene sequencing

    Regeneron Pharmaceuticals has formed a pre-competitive consortium with AbbVie, Alnylam Pharmaceuticals, AstraZeneca, Biogen and Pfizer to accelerate its gene sequencing…
    Read More…

    10 Jan
  5. Teva and Alder sign global licence agreement on anti-CGRP therapy

    Teva Pharmaceuticals International has entered a global licence agreement with Alder BioPharmaceuticals for anti-calcitonin gene-related peptide (CGRP) antibodies and their…
    Read More…

    10 Jan
  6. Takeda plans to acquire TiGenix for €520m

    Takeda Pharmaceutical is planning to purchase Belgium-based biopharmaceutical company TiGenix for €1.78 per share, amounting to a total value of…
    Read More…

    9 Jan
  7. Sanofi and Alnylam restructure RNAi rare disease alliance

    Sanofi and Alnylam have entered a strategic restructuring of their RNAi therapeutics collaboration to optimise the development and commercialisation of…
    Read More…

    9 Jan
  8. Ablynx rejects Novo Nordisk’s acquisition proposal

    Belgium-based biotech firm Ablynx has rejected a proposal made by Denmark’s Novo Nordisk to purchase all of its outstanding shares…
    Read More…

    9 Jan
  9. Beacon enters drug discovery collaboration with Janssen

    US-based drug discovery firm Beacon Discovery has entered a multi-year collaboration agreement with Janssen Pharmaceuticals for small molecule compounds to…
    Read More…

    8 Jan
  10. FDA grants fast-track designation to malaria drug Tafenoquine

    The US Food and Drug Administration (FDA) has granted fast-track designation to 60 Degrees Pharmaceuticals’ (60P) Tafenoquine for the prevention…
    Read More…

    8 Jan
Close
Close
Close

Go Top